Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank14
Studio
Year-over-Year Change

Return on equity

Latest
-55.42%
↓ 22% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-45.51%
Historical baseline
PeriodValueYoY Change
2025-55.42%+0.8%
2024-55.85%-55.9%
2023-35.83%-9.5%
2022-32.72%-87.0%
2021-17.49%+66.4%
2020-52.12%+18.4%
2019-63.90%-42.0%
2018-44.99%+4.9%
2017-47.32%+4.4%
2016-49.48%-